Treatment for elderly patients with acute non-lymphocytic leukemia

• Published in: Rinshō ketsueki Vol. 36; no. 2; p. 91
• Main Authors: Fujisawa, S, Maruta, A, Ogawa, K, Sakai, R, Taguchi, J, Tomita, N, Kodama, F, Sasaki, S, Fukawa, H, Murata, T
• Format: Journal Article
• Language: Japanese
• Published: Japan 01.02.1995
• Subjects: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine - administration & dosage; Cytarabine - analogs & derivatives; Daunorubicin - administration & dosage; Female; Humans; Male; Mercaptopurine - administration & dosage; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality; Prednisolone - administration & dosage; Remission Induction; Retrospective Studies; Survival Rate

A retrospective analysis was performed on forty nine elderly (34 males and 15 females) patients aged 65 years or more (median age 73, range 65-82) with acute non-lymphocytic leukemia (ANLL). Patients were studied to examine factors according to age group (65-69 years, 70-74, 75-79 and 80 or over), r...